©2020 by Solas BioVentures

2016

Solas BioVentures to Seek Up to $100M for Second Early-Stage Fund

SEPT 2, 2016

Drug Developer Arrivo BioVentures Launches With $49M 

MAY 25, 2016

CardioNXT Secures Additional $1.5M Funding From Solas BioVentures To Drive Atrial Fibrillation Treatment Innovation

MAY 24, 2016